Future and implications of reimbursement for obesity treatment

Judith S. Stern, Alexandra Kazaks, Morgan Downey

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Obesity has been defined as a distinct disease by the World Health Organization, National Institutes of Health, Centers for Disease Control and Prevention, and the American Dietetic Association. In the United States, a major reimbursement challenge is to promote acceptance of obesity as a chronic disease and acceptance of its treatment by health management organizations, private insurers, and the government. The United States health care system is focused on treating individual obesity-related diseases, but does not treat obesity as the underlying cause. Reimbursement of obesity treatments using "condition coverage" based on the presence of other diseases does not allow obesity to be treated independently as a disease in itself. It is necessary to make major investments in research to determine the best methods and to match the treatment with the individual, to prevent obesity in vulnerable populations, and to develop more effective drugs and treatments for those already overweight or obese. There should be a more detailed analysis of the cost of obesity, costs associated with obesity and obesity-related disease treatment, and costs of inaction. The obesity epidemic is too large to be ignored. Health care professionals have a duty to be informed about the disease and to advocate for patients who need help. Registered dietitians can be key players in delivering obesity treatment.

Original languageEnglish (US)
JournalJournal of the American Dietetic Association
Volume105
Issue number5 SUPPL.
DOIs
StatePublished - May 2005

Fingerprint

obesity
Obesity
obesity-related diseases
Therapeutics
National Institutes of Health
Centers for Disease Control and Prevention
cost analysis
Delivery of Health Care
World Health Organization
dietitians
dietetics
health care workers
Insurance Carriers
Cost of Illness
Dietetics
chronic diseases
Nutritionists
health services
National Institutes of Health (U.S.)
Vulnerable Populations

ASJC Scopus subject areas

  • Food Science
  • Medicine(all)

Cite this

Future and implications of reimbursement for obesity treatment. / Stern, Judith S.; Kazaks, Alexandra; Downey, Morgan.

In: Journal of the American Dietetic Association, Vol. 105, No. 5 SUPPL., 05.2005.

Research output: Contribution to journalArticle

Stern, Judith S. ; Kazaks, Alexandra ; Downey, Morgan. / Future and implications of reimbursement for obesity treatment. In: Journal of the American Dietetic Association. 2005 ; Vol. 105, No. 5 SUPPL.
@article{93b4a0559c2b42b09d316e7261faff34,
title = "Future and implications of reimbursement for obesity treatment",
abstract = "Obesity has been defined as a distinct disease by the World Health Organization, National Institutes of Health, Centers for Disease Control and Prevention, and the American Dietetic Association. In the United States, a major reimbursement challenge is to promote acceptance of obesity as a chronic disease and acceptance of its treatment by health management organizations, private insurers, and the government. The United States health care system is focused on treating individual obesity-related diseases, but does not treat obesity as the underlying cause. Reimbursement of obesity treatments using {"}condition coverage{"} based on the presence of other diseases does not allow obesity to be treated independently as a disease in itself. It is necessary to make major investments in research to determine the best methods and to match the treatment with the individual, to prevent obesity in vulnerable populations, and to develop more effective drugs and treatments for those already overweight or obese. There should be a more detailed analysis of the cost of obesity, costs associated with obesity and obesity-related disease treatment, and costs of inaction. The obesity epidemic is too large to be ignored. Health care professionals have a duty to be informed about the disease and to advocate for patients who need help. Registered dietitians can be key players in delivering obesity treatment.",
author = "Stern, {Judith S.} and Alexandra Kazaks and Morgan Downey",
year = "2005",
month = "5",
doi = "10.1016/j.jada.2005.02.048",
language = "English (US)",
volume = "105",
journal = "Journal of the Academy of Nutrition and Dietetics",
issn = "2212-2672",
publisher = "Elsevier USA",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Future and implications of reimbursement for obesity treatment

AU - Stern, Judith S.

AU - Kazaks, Alexandra

AU - Downey, Morgan

PY - 2005/5

Y1 - 2005/5

N2 - Obesity has been defined as a distinct disease by the World Health Organization, National Institutes of Health, Centers for Disease Control and Prevention, and the American Dietetic Association. In the United States, a major reimbursement challenge is to promote acceptance of obesity as a chronic disease and acceptance of its treatment by health management organizations, private insurers, and the government. The United States health care system is focused on treating individual obesity-related diseases, but does not treat obesity as the underlying cause. Reimbursement of obesity treatments using "condition coverage" based on the presence of other diseases does not allow obesity to be treated independently as a disease in itself. It is necessary to make major investments in research to determine the best methods and to match the treatment with the individual, to prevent obesity in vulnerable populations, and to develop more effective drugs and treatments for those already overweight or obese. There should be a more detailed analysis of the cost of obesity, costs associated with obesity and obesity-related disease treatment, and costs of inaction. The obesity epidemic is too large to be ignored. Health care professionals have a duty to be informed about the disease and to advocate for patients who need help. Registered dietitians can be key players in delivering obesity treatment.

AB - Obesity has been defined as a distinct disease by the World Health Organization, National Institutes of Health, Centers for Disease Control and Prevention, and the American Dietetic Association. In the United States, a major reimbursement challenge is to promote acceptance of obesity as a chronic disease and acceptance of its treatment by health management organizations, private insurers, and the government. The United States health care system is focused on treating individual obesity-related diseases, but does not treat obesity as the underlying cause. Reimbursement of obesity treatments using "condition coverage" based on the presence of other diseases does not allow obesity to be treated independently as a disease in itself. It is necessary to make major investments in research to determine the best methods and to match the treatment with the individual, to prevent obesity in vulnerable populations, and to develop more effective drugs and treatments for those already overweight or obese. There should be a more detailed analysis of the cost of obesity, costs associated with obesity and obesity-related disease treatment, and costs of inaction. The obesity epidemic is too large to be ignored. Health care professionals have a duty to be informed about the disease and to advocate for patients who need help. Registered dietitians can be key players in delivering obesity treatment.

UR - http://www.scopus.com/inward/record.url?scp=18144429430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144429430&partnerID=8YFLogxK

U2 - 10.1016/j.jada.2005.02.048

DO - 10.1016/j.jada.2005.02.048

M3 - Article

C2 - 15867905

AN - SCOPUS:18144429430

VL - 105

JO - Journal of the Academy of Nutrition and Dietetics

JF - Journal of the Academy of Nutrition and Dietetics

SN - 2212-2672

IS - 5 SUPPL.

ER -